|
|
Home > Healthcare > Pharmaceutical > General Pharmaceutical
Top 50 Pharmaceutical Companies Report
|
|
The Global Top 50 Pharmaceutical Companies Report
Plimsoll Publishing Ltd.
Do you know....
The top 7 best trading partners in the industry?
Which company has the highest sales growth?
Which companies have the highest levels of debt?
This report is an in-depth financial evaluation of the Global Top 50 Pharmaceutical Companies. Using the unique Plimsoll method of analysis, each of the top 50 Global Pharmaceutical Companies is individually assessed and ranked against each other and compared to industry averages. Using the most up-to-date financial information available, the two-page analysis provides detailed financial analysis for each organisation, including details of; - Sales growth
- Trading stability
- Profitability
- Employee performance
- Level of debt
- Gearing ratio’s
- Creditor Exposure
- Performance ratio’s
- Overall financial rating
Results are shown in graphical, numeric and narrative forms, and all individual analysis are measured in both the company’s own currency, and USD ($) for ease of use. These individual analyses highlight a company’s success just as easily as it can emphasise its vulnerability.
Along with individual company information, this report also contains an assesment of the market, based on the companies analysed. This key information identifies;- Best trading partners (based on commercial and financial strength)
- Sales growth (highest sales, growth rate, size of market based on the companies analysed, average growth)
- Profitability (Profit return on assets, pre-tax profit margins, industry average)
- Fastest growing companies (performance matrix)
Companies can change at an alarming rate in a very short space of time, so it is vital that you keep up-to-date with any changes to your market, and how those changes can affect you. This report can provide you with an in-depth look at your industry, highlight new market opportunities and provide important information to help develop accurate strategic business plans. Whether you wish to benchmark your own company’s results, study the industry in more depth or have a vast array of industry intelligence at your disposal, this report is the ideal resource.
|
Similar Products
• United States Type 2 Diabetes Market
Published Nov 2009 by Intellent
• Company Financials: Bayer AG
Published Nov 2009 by Datamonitor
• Thailand Pharmaceuticals and Healthcare Report Q1 2010
Published Nov 2009 by Business Monitor International
• Argentina Pharmaceuticals and Healthcare Report Q1 2010
Published Nov 2009 by Business Monitor International
• Takeda Pipeline, Products, Performance, Potential
Published Nov 2009 by Espicom Healthcare Intelligence
• Poland Pharmaceuticals and Healthcare Report Q1 2010
Published Nov 2009 by Business Monitor International
• Merck & Co. Performance, Products, Pipeline and Potential
Published Nov 2009 by Espicom Healthcare Intelligence
• Australia Pharmaceuticals and Healthcare Report Q1 2010
Published Nov 2009 by Business Monitor International
• Nigeria Pharmaceuticals and Healthcare Report Q1 2010
Published Nov 2009 by Business Monitor International
• Kenya Pharmaceuticals and Healthcare Report Q1 2010
Published Nov 2009 by Business Monitor International
|
|
|
|
0 items
